170 related articles for article (PubMed ID: 28286967)
1. Protective effect of glucagon-like peptide-1 agents on reperfusion injury for acute myocardial infarction: a meta-analysis of randomized controlled trials.
Huang M; Wei R; Wang Y; Su T; Li Q; Yang X; Chen X
Ann Med; 2017 Nov; 49(7):552-561. PubMed ID: 28286967
[TBL] [Abstract][Full Text] [Related]
2. Role of glucagon-like peptide-1 agonist in patients undergoing percutaneous coronary intervention or coronary artery bypass grafting: A meta-analysis.
Ogbu IR; Ngwudike C; Lal K; Danielian A; Daoud SN
Am Heart J Plus; 2021 Nov; 11():100063. PubMed ID: 38549742
[TBL] [Abstract][Full Text] [Related]
3. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.
Nikolaidis LA; Mankad S; Sokos GG; Miske G; Shah A; Elahi D; Shannon RP
Circulation; 2004 Mar; 109(8):962-5. PubMed ID: 14981009
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin treatment in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
Gao D; Ning N; Niu X; Dang Y; Dong X; Wei J; Zhu C
Am Heart J; 2012 Nov; 164(5):715-727.e1. PubMed ID: 23137502
[TBL] [Abstract][Full Text] [Related]
6. Effects of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) on Cardiac Structure and Function: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.
Wong SY; Lee ARYB; Sia AHJ; Wo YJ; Teo YH; Teo YN; Syn NL; Ong CC; Teo LL; Yeo TC; Poh KK; Kong WK; Wong RC; Sia CH
Cardiovasc Drugs Ther; 2024 Apr; 38(2):371-389. PubMed ID: 35819544
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
Kang S; Yang Y; Li CJ; Gao R
Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
[TBL] [Abstract][Full Text] [Related]
8. Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.
Wu M; Huang Z; Xie H; Zhou Z
PLoS One; 2013; 8(10):e78231. PubMed ID: 24167609
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A PRISMA-Compliant Meta-Analysis.
Gao Q; Yang B; Guo Y; Zheng F
Medicine (Baltimore); 2015 Aug; 94(32):e1279. PubMed ID: 26266362
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of Glucagon-Like Peptide-1 Receptor Agonists to Reduce Adverse Cardiovascular Disease Events in Patients with Type 2 Diabetes Mellitus.
Grewal S; Zaman N; Borgatta L; Nudy M; Foy AJ; Peterson B
Am J Cardiol; 2021 Sep; 154():48-53. PubMed ID: 34266665
[TBL] [Abstract][Full Text] [Related]
11. Update in Cardiovascular Safety of Glucagon Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes. A Mixed Treatment Comparison Meta-Analysis of Randomised Controlled Trials.
Al Yami MS; Alfayez OM; Alsheikh R
Heart Lung Circ; 2018 Nov; 27(11):1301-1309. PubMed ID: 29887418
[TBL] [Abstract][Full Text] [Related]
12. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials.
Kumbhani DJ; Bavry AA; Desai MY; Bangalore S; Bhatt DL
J Am Coll Cardiol; 2013 Oct; 62(16):1409-18. PubMed ID: 23665372
[TBL] [Abstract][Full Text] [Related]
13. The role of Glucagon-Like Peptide 1 Loading on periprocedural myocardial infarction During elective PCI (GOLD-PCI study): A randomized, placebo-controlled trial.
Giblett JP; Clarke S; Zhao T; McCormick LM; Braganza DM; Densem CG; O'Sullivan M; Adlam D; Clarke SC; Steele J; Fielding S; West NEJ; Villar SS; Hoole SP
Am Heart J; 2019 Sep; 215():41-51. PubMed ID: 31277053
[TBL] [Abstract][Full Text] [Related]
14. Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials.
Monami M; Zannoni S; Pala L; Silverii A; Andreozzi F; Sesti G; Mannucci E
Int J Cardiol; 2017 Aug; 240():414-421. PubMed ID: 28501352
[TBL] [Abstract][Full Text] [Related]
15. Postconditioning in patients treated with primary percutaneous coronary intervention: an updated meta-analysis.
Wang L; Wang J; Xu H; Li B
Catheter Cardiovasc Interv; 2013 Nov; 82(5):E662-71. PubMed ID: 23804529
[TBL] [Abstract][Full Text] [Related]
16. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Ji Z; Zhang R; Lu W; Ma G; Qu Y
Ir J Med Sci; 2020 Feb; 189(1):119-131. PubMed ID: 31147987
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
19. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials.
Delewi R; Andriessen A; Tijssen JG; Zijlstra F; Piek JJ; Hirsch A
Heart; 2013 Feb; 99(4):225-32. PubMed ID: 22875736
[TBL] [Abstract][Full Text] [Related]
20. No benefit of additional treatment with exenatide in patients with an acute myocardial infarction.
Roos ST; Timmers L; Biesbroek PS; Nijveldt R; Kamp O; van Rossum AC; van Hout GP; Stella PR; Doevendans PA; Knaapen P; Velthuis BK; van Royen N; Voskuil M; Nap A; Appelman Y
Int J Cardiol; 2016 Oct; 220():809-14. PubMed ID: 27394978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
